Accepted answer
At 2 mg/mL a 0.25 mg draw is 12.5 units on a U-100 barrel and a 2.4 mg draw is 120. Those two numbers decide it, because the concentration is only sensible relative to the smallest and largest volumes you will actually measure with it. 120 units will not fit a 1 mL U-100 barrel in one draw, which makes the large end the constraint rather than the small one. The other consideration is time: a vial you will finish in a fortnight can be concentrated, and a vial you will draw from for months should be split at reconstitution instead.
The short version: more diluent means a lower concentration, a larger volume per dose and a finer reading; less means the opposite.
Worked example. A 10 mg vial reconstituted with 2 mL gives 5 mg/mL. A 0.5 mg dose is 0.5 ÷ 5 = 0.1 mL, which on a U-100 syringe is 10 units. Reconstitute the same vial with 1 mL and the concentration doubles to 10 mg/mL, the same dose becomes 0.05 mL, and you are now reading 5 units instead of 10 — the same dose at half the resolution.
In practice, dead-space loss scales with the number of draws, not with the concentration, so a lower concentration spread over more draws loses proportionally less of the total peptide.
U-100 means 100 units per millilitre by definition, so 1 unit is 0.01 mL and volume in millilitres times one hundred gives units. Every conversion here reduces to that.
The caveat is that this arithmetic assumes the vial contains what the label says, and without a content assay it is precise about an unknown quantity.
Check the vial can physically hold the volume before you draw it up.
Would this be different for a peptide that foams? Mine does and I have never known why. – ravi_pillai 8 months ago Adding that a fixed-needle syringe loses about a tenth of what a luer one does. – tess_amankwah 10 months ago add a comment